Texas 2025 - 89th Regular

Texas Senate Bill SB2470 Compare Versions

Only one version of the bill is available at this time.

Old	New	Differences
1	1	89R13930 AND-D
2	2	By: Menéndez S.B. No. 2470
3	3
4	4
5	5
6	6
7	7	A BILL TO BE ENTITLED
8	8	AN ACT
9	9	relating to the requirements for the labeling and dispensing of a
10	10	prescription drug or biological product.
11	11	BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS:
12	12	SECTION 1. Section 562.006, Occupations Code, is amended by
13	13	amending Subsections (b) and (f) and adding Subsection (g) to read
14	14	as follows:
15	15	(b) In addition to the information required by Subsection
16	16	(a), the label on the dispensing container of a drug or biological
17	17	product dispensed by a Class A or Class E pharmacy must [indicate]:
18	18	(1) indicate:
19	19	(A) the name, address, and telephone number of
20	20	the pharmacy;
21	21	(B) [(2)] the date the prescription is
22	22	dispensed;
23	23	(C) [(3)] the name of the prescribing
24	24	practitioner;
25	25	(D) [(4)] the name of the patient or, if the drug
26	26	or biological product was prescribed for an animal, the species of
27	27	the animal and the name of the owner;
28	28	(E) [(5)] instructions for use;
29	29	(F) [(6)] the quantity dispensed;
30	30	(G) [(7)] if the drug or biological product is
31	31	dispensed in a container other than the manufacturer's original
32	32	container, the date after which the prescription should not be
33	33	used, determined according to criteria established by board rule
34	34	based on standards in the United States Pharmacopeia-National
35	35	Formulary; and
36	36	(H) [(8)] any other information required by
37	37	board rule; and
38	38	(2) include, in a format accessible to the patient
39	39	through a mobile Internet application or assistive technology
40	40	electronic device available to the patient at no cost, the
41	41	information described by Subdivision (1) and information regarding
42	42	potential side effects and contraindicated medications.
43	43	(f) The [board shall adopt rules requiring the] label on a
44	44	dispensing container must [to] be in plain language and printed in
45	45	Times New Roman with a minimum of 12-point [an easily readable] font
46	46	size [for the consumer].
47	47	(g) A pharmacist at a Class A or Class E pharmacy shall, on a
48	48	patient's request, provide to the patient a large-print data sheet
49	49	containing:
50	50	(1) the information required under Subsection (b)(1)
51	51	to be on the label on a dispensing container of a drug or biological
52	52	product dispensed to the patient; and
53	53	(2) information regarding potential side effects and
54	54	contraindicated medications for the drug or biological product
55	55	dispensed to the patient.
56	56	SECTION 2. Not later than January 1, 2026, the Texas State
57	57	Board of Pharmacy shall adopt any rules necessary to implement the
58	58	changes in law made by this Act.
59	59	SECTION 3. The changes in law made by this Act apply only to
60	60	a drug or biological product dispensed on or after March 1, 2026. A
61	61	drug or biological product dispensed before March 1, 2026, is
62	62	governed by the law in effect immediately before the effective date
63	63	of this Act, and the former law is continued in effect for that
64	64	purpose.
65	65	SECTION 4. This Act takes effect September 1, 2025.